[Form 4] Insmed, Inc. Insider Trading Activity
Insider Trade Summary
Exercise and Sale: 6,830 shares ($598K approx. pre-tax spread)
Exercise and Sale
7 txns
Insider
Lewis William
Role
Chair and CEO
Sold
6,830 shs ($672K)
Approx. gross sale proceeds
$672K
Approx. exercise cost
$74K
Approx. pre-tax spread
$598K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 6,830 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,830 | $10.85 | $74K |
| Sale | Common Stock | 3,666 | $97.73 | $358K |
| Sale | Common Stock | 2,349 | $98.83 | $232K |
| Sale | Common Stock | 815 | $99.61 | $81K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 20,525 shares (Indirect, By the Katie Procter Dynasty Trust);
Common Stock — 233,924 shares (Indirect, By the Katie Procter Dynasty Trust);
Common Stock — 303,911 shares (Direct);
Common Stock — 50,500 shares (Indirect, By the William Lewis Family Legacy Trust)
Footnotes (6)
- F1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2. This is the weighted average sales price representing 3,666 shares sold at prices ranging from $97.40 to $98.38 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F3. This is the weighted average sales price representing 2,349 shares sold at prices ranging from $98.40 to $99.39 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F4. This is the weighted average sales price representing 815 shares sold at prices ranging from $99.40 to $100.26 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F5. Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
- F6. The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
